阿托伐他汀下调活性caspase-9/caspase-3的表达抑制H2O2诱导的血管内皮细胞凋亡
Atorvastatin inhibits the H2O2-induced apoptosis of human vascular endothelial cells through a down-regulation of cleaved caspase-9/caspase-3
摘要
目的 探讨阿托伐他汀在过氧化氢( H2O2)诱导的血管内皮细胞凋亡中的作用,以及内在分子机制.方法 采用H2O2(100 μmol/L)损伤ECV-304细胞18h建立细胞凋亡模型,予以不同浓度阿托伐他汀(0.1、1和10 μmol/L)预处理2h,利用荧光显微镜观察细胞形态变化,MTT检测细胞活性,流式细胞技术测定凋亡细胞比例,最后采用Western印迹方法检测活性片段caspase-3和caspase-9的表达.结果 H2O2损伤导致ECV-304细胞发生明显的凋亡形态学改变,细胞活性显著下降,凋亡细胞比例高达50.71%.经过不同浓度阿托伐他汀预处理后,细胞活性明显恢复,凋亡细胞比例显著减少(39.45%、20.53%和7.83%).Western印迹检测发现,H202损伤组caspase-3和caspase-9活性片段表达非常明显,阿托伐他汀预处理后,两者表达水平下降,并且呈现明显的剂量依赖性.结论阿托伐他汀具有抑制H202诱导的血管内皮细胞凋亡的作用,并且这一作用呈现剂量依赖性;caspase-9/caspase-3活性片段表达水平降低与阿托伐他汀的这一保护作用有关.
Objective To investigate the effect and potential mechanism of atorvastatin against H2O2-induced apoptosis of human umbilical vein endothelial ceils (ECV-304).Methods ECV-304 cells were pretreated with different concentrations of atorvastatin (0.1,1 and 10 μmol/L) for2 h,followed by an exposure to 100 μ mol/L H2O2 for 18 h.Cellular morphology was observed under fluorescence microscope.Cellular viability and apoptosis were evaluated by methyl thiazolyl tetrazolium (MTT) and flow cytometry.Finally the expressions of cleaved caspase-3 and caspase-9 were measured by Western blot.Results H2O2 treatment caused an obvious apoptosis of ECV-304 cells and significantly decreased the cellular viability as characterized by a high percentage (50.71% ) of apoptotic cells.Atorvastatin pretreatment inhibit cellular apoptosis induced by H2O2 (39.45%,20.53% and 7.83% ).Western blot assay showed that H2O2 treatment caused a high expression of cleaved caspase-3 and caspase-9 while atorvastatin pretreatment obviously inhibited the expression in a dose-dependent manner. Conclusions Atorvastatin inhibits the H2O2-induced apoptosis of ECV-304 cells in a dose-dependent manner.This effect may be associated with the down-regulation of cleaved caspase-9/caspase-3.
Author:
XU Zhe-rong
YAO Hang-ping
LI Su-jun
WU Wei-zhen
YANG Yun-mei
作者单位:
浙江大学医学院附属第一医院老年病科, 杭州,310003
浙江大学医学院附属第一医院 传染病诊治国家重点实验室, 杭州,310003
年,卷(期):
2012, 92(24)
分类号:
R4
机标分类号:
R972+.6
R735.7
R363
在线出版日期:
2012年10月24日
基金项目:
ZC200804919:教育厅科学研究项目2008CB034:浙江省中医药局科研项目,